Instituto de Salud Carlos III recognizes again the potential and excellence of IDIS as a reference center on the national scene and accredits it to carry out its work over the next five years
The strengths Health Research Institute of the Santiago de Compostela (IDIS) have just been recognized once again by the Instituto de Salud Carlos III. In an act chaired by the Healthcare regional Minister, Jesús Almuiña, and the Rector of the USC, Antonio López, the center led by Dr. José Castillo, achieved reaccreditation as a health research institute, a milestone that enables him to carry out his work for five more years. This is the second process of reaccreditation that passes the IDIS, being at the forefront of biomedical science in Galicia and Spain.
Balance positivo del ejercicio 2019
Positive balance for the 2019 financial year
Also yesterday, the most significant data for the 2019 financial year were released, approving its Annual Activity Report. The indicators, with increases in all its areas, reveal an increase in funds raised of 10% compared to the previous year, with a total of 32,208,340 euros. The 92 active projects (57 national, 15 international and 20 regional) and an increase of more than 50% (56.3%) in funds destined to the development of these programs stand out.
In the Human Resources chapter, last year allowed the hiring of 65 people. Thus, they join the 1,280 professionals who make up the Institute (209 more than the previous year), integrated into 94 groups organized in 6 research areas: oncology, genetics and systems biology, endocrinology, neurosciences, platforms, and methodology and inflammation. Scientific production was remarkably increased, with 839 articles published in nearly 500 prestigious international journals and the defense of 64 theses under IDIS.
The transfer to society through industry also had a positive result with 44 patents applied for and 7 already granted; and 5 spin-off companies created within the Institute.
IDIS marks a new competitive horizon for 2025, already thinking about the next reaccreditation. During this time, according to its director José Castillo, “we set ourselves a series of strategic objectives that, fundamentally, go through maintaining the increase in all of our activity indicators, stabilizing the talent of our researchers and technical personnel and being closer to the society”.
The roadmap has several main lines: “our influence groups and society as a whole must perceive the importance of research work and our role as liaison with industry and healthcare medicine, that is the path of excellence” Castillo acknowledges. Making the integration of the healthcare area of Lugo more effective, with more infrastructures and collaborations with reference centers and increasing spaces to favor the development of projects, are other challenges that IDIS also sets itself.
The agreement between the Galician Public Health Service (SERGAS) and the USC is also reactivated to regulate the operation of IDIS in a collaborative regime, reinforcing the links between both organizations
Yesterday’s meeting also made way for the agreement that will regulate the functional dependency of IDIS, the equal parts, of the Regional Ministry of Health-SERGAS and the USC. This link highlights the synergies between the two entities and the joint commitment to health research and the leadership of institutes such as IDIS that contribute to creating the Galicia brand and projecting it on a large scale.